These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16734550)

  • 1. A highly sensitive immunoassay resistant to autoantibody interference for detection of the diabetes-associated autoantigen glutamic acid decarboxylase 65 in blood and other biological samples.
    Waldrop MA; Suckow AT; Hall TR; Hampe CS; Marcovina SM; Chessler SD
    Diabetes Technol Ther; 2006 Apr; 8(2):207-18. PubMed ID: 16734550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.
    Kim J; Richter W; Aanstoot HJ; Shi Y; Fu Q; Rajotte R; Warnock G; Baekkeskov S
    Diabetes; 1993 Dec; 42(12):1799-808. PubMed ID: 8243826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive monoclonal antibody-based sandwich ELISA for determination of the diabetes-associated autoantigen glutamic acid decarboxylase GAD65.
    Schlosser M; Hahmann J; Ziegler B; Augstein P; Ziegler M
    J Immunoassay; 1997 Nov; 18(4):289-307. PubMed ID: 9358337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of glutamate decarboxylase-65 into the circulation by injured pancreatic islet beta-cells.
    Waldrop MA; Suckow AT; Marcovina SM; Chessler SD
    Endocrinology; 2007 Oct; 148(10):4572-8. PubMed ID: 17584960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein.
    Luo D; Rogers CN; Steed JT; Gilliam LK; Hampe CS; Lernmark A
    J Biotechnol; 2004 Jul; 111(1):97-104. PubMed ID: 15196774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay for glutamic acid decarboxylase-65.
    Hao W; Daniels T; Pipeleers DG; Smismans A; Reijonen H; Nepom GT; Lernmark A
    Diabetes Technol Ther; 1999; 1(1):13-20. PubMed ID: 11475299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of recombinant glutamic acid decarboxylase in insect larvae and its application in an immunoassay for the diagnosis of autoimmune diabetes mellitus.
    Trabucchi A; Bombicino SS; Targovnik AM; Marfía JI; Sabljic AV; Faccinetti NI; Guerra LL; Iacono RF; Miranda MV; Valdez SN
    Sci Rep; 2019 Jan; 9(1):824. PubMed ID: 30696851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies.
    Marcovina SM; Landin-Olsson M; Essen-Möller A; Palmer JP; Lernmark A
    Int J Clin Lab Res; 2000; 30(1):21-6. PubMed ID: 10984128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
    Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of glutamic acid decarboxylase (GAD65) in pancreatic islets and its in vitro and in vivo degradation kinetics in serum using a highly sensitive enzyme immunoassay.
    Schlosser M; Walschus U; Klöting I; Walther R
    Dis Markers; 2008; 24(3):191-8. PubMed ID: 18334741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome.
    Gu Urban GJ; Friedman M; Ren P; Törn C; Fex M; Hampe CS; Lernmark Å; Landegren U; Kamali-Moghaddam M
    Sci Rep; 2015 Jun; 5():11196. PubMed ID: 26080009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.
    Hagopian WA; Karlsen AE; Gottsäter A; Landin-Olsson M; Grubin CE; Sundkvist G; Petersen JS; Boel E; Dyrberg T; Lernmark A
    J Clin Invest; 1993 Jan; 91(1):368-74. PubMed ID: 8423232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with GAD65 or BSA does not protect against diabetes in BB rats.
    Petersen JS; Mackay P; Plesner A; Karlsen A; Gotfredsen C; Verland S; Michelsen B; Dyrberg T
    Autoimmunity; 1997; 25(3):129-38. PubMed ID: 9272278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an Enhanced Sensitivity Bead-Based Immunoassay for Real-Time In Vivo Detection of Pancreatic β-Cell Death.
    Costa OR; Stangé G; Verhaeghen K; Brackeva B; Nonneman E; Hampe CS; Ling Z; Pipeleers D; Gorus FK; Martens GA
    Endocrinology; 2015 Dec; 156(12):4755-60. PubMed ID: 26431226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands.
    Falorni A; Ortqvist E; Persson B; Lernmark A
    J Immunol Methods; 1995 Oct; 186(1):89-99. PubMed ID: 7561152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamic acid decarboxylase-67 (GAD67): expression relative to GAD65 in human islets and mapping of autoantibody epitopes.
    Cram DS; Faulkner-Jones B; Kun J; Harrison LC
    Endocrinology; 1995 Mar; 136(3):1111-9. PubMed ID: 7532577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.